In conclusion, a complex interplay of genetic changes, such as MYCN amplification, segmental chromosomal modifications, gene expression profiles, ALK mutations, and other genomic variants, contributes to the complex pathogenesis of neuroblastoma. Here, ALK is linked to neuroblastoma.